Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis
- PMID: 15262732
- DOI: 10.1001/archneur.61.7.1025
Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis
Abstract
Background: Paroxysmal dystonic choreoathetosis (PDC) is characterized by attacks of involuntary movements that occur spontaneously while at rest and following caffeine or alcohol consumption. Previously, we and others identified a locus for autosomal dominant PDC on chromosome 2q33-2q35.
Objective: To identify the PDC gene.
Design: Analysis of PDC positional candidate genes by exon sequencing and reverse transcription-polymerase chain reaction.
Setting: Outpatient clinical and molecular genetic laboratory at a university hospital. Patients Affected (n = 12) and unaffected (n = 26) subjects from 2 unrelated families with PDC and 105 unrelated control subjects.
Results: We identified missense mutations in the myofibrillogenesis regulator gene (MR-1) in affected subjects in 2 unrelated PDC kindreds. These mutations were absent in control subjects and caused substitutions of valine for alanine at amino acid positions 7 and 9. The substitutions disturb interspecies conserved residues and are predicted to alter the MR-1 gene's amino-terminal alpha helix. The MR-1 exon containing these mutations (exon 1) was expressed only in the brain, a finding that explains the brain-specific symptoms of subjects with these mutations.
Conclusions: Although MR-1 gene function is unknown, the precedence of ion channel disturbance in other episodic neurologic disorders suggests that the pathophysiologic features of PDC also involve abnormal ion localization. The discovery that MR-1 mutations underlie PDC provides opportunities to explore this condition's pathophysiologic characteristics and may provide insight into the causes of other paroxysmal neurologic disorders as well as the neurophysiologic mechanisms of alcohol and caffeine, which frequently precipitate PDC attacks.
Comment in
-
Genes for movement.Arch Neurol. 2004 Jul;61(7):1006. doi: 10.1001/archneur.61.7.1006. Arch Neurol. 2004. PMID: 15262727 No abstract available.
-
Genes for movement.Arch Neurol. 2004 Aug;61(8):1182. doi: 10.1001/archneur.61.8.1182. Arch Neurol. 2004. PMID: 15313833 No abstract available.
Similar articles
-
Presence of alanine-to-valine substitutions in myofibrillogenesis regulator 1 in paroxysmal nonkinesigenic dyskinesia: confirmation in 2 kindreds.Arch Neurol. 2005 Apr;62(4):597-600. doi: 10.1001/archneur.62.4.597. Arch Neurol. 2005. PMID: 15824259
-
Acid-sensing ion channel (ASIC) 4 gene: physical mapping, genomic organisation, and evaluation as a candidate for paroxysmal dystonia.Eur J Hum Genet. 2001 Sep;9(9):672-6. doi: 10.1038/sj.ejhg.5200699. Eur J Hum Genet. 2001. PMID: 11571555
-
Familial paroxysmal dystonic choreoathetosis revisited.Mov Disord. 1996 May;11(3):317-20. doi: 10.1002/mds.870110316. Mov Disord. 1996. PMID: 8723150
-
[Paroxysmal dystonic choreoathetosis linked to chromosome 2 (PDC)].Ryoikibetsu Shokogun Shirizu. 1999;(27 Pt 2):115-7. Ryoikibetsu Shokogun Shirizu. 1999. PMID: 10434607 Review. Japanese. No abstract available.
-
A novel mutation in the dihydrolipoamide dehydrogenase E3 subunit gene (DLD) resulting in an atypical form of alpha-ketoglutarate dehydrogenase deficiency.Hum Mutat. 2005 Mar;25(3):323-4. doi: 10.1002/humu.9319. Hum Mutat. 2005. PMID: 15712224 Review.
Cited by
-
The genetics of dystonias.Adv Genet. 2012;79:35-85. doi: 10.1016/B978-0-12-394395-8.00002-5. Adv Genet. 2012. PMID: 22989765 Free PMC article. Review.
-
Analyzing clinical and electrophysiological characteristics of Paroxysmal Dyskinesia.J Res Med Sci. 2011 Jan;16(1):110-4. J Res Med Sci. 2011. PMID: 21448393 Free PMC article.
-
Genetic and phenotypic heterogeneity in sporadic and familial forms of paroxysmal dyskinesia.J Neurol. 2013 Jan;260(1):93-9. doi: 10.1007/s00415-012-6592-5. Epub 2012 Jun 30. J Neurol. 2013. PMID: 22752065 Free PMC article.
-
Neuroanatomical substrates for paroxysmal dyskinesia in lethargic mice.Neurobiol Dis. 2007 Sep;27(3):249-57. doi: 10.1016/j.nbd.2007.05.001. Epub 2007 May 10. Neurobiol Dis. 2007. PMID: 17561408 Free PMC article.
-
Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer.BMC Cancer. 2011 Jun 25;11:270. doi: 10.1186/1471-2407-11-270. BMC Cancer. 2011. PMID: 21702971 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases